154 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
hematology and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational
8-K
EX-99.1
y9fc5c57cb08n9y
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
y2rl28 508
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
jf7a2
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
gg7i8oh
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
0tc5v6qs
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
iasro3
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-99.1
ntp0d5 sx0o831k
27 Oct 22
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
4:20pm
8-K
EX-99.1
z0651
19 Sep 22
Agios Appoints Cecilia Jones as Chief Financial Officer
7:08am
8-K
EX-99.1
hi59myju
4 Aug 22
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
7:14am